Header Logo
Newsletter Podcast
Log In
← Back to all posts

Game-Changing PRP Data, $7 Sling Hack, and What Most Marketing Gets Wrong

Jun 03, 2025
Connect

Highlights

  • Today’s Research Article: PRP Beats Steroids for Disc Pain — Backed by Real Patients, Real Results.
  • Questions from the Field: How Much Anesthetic? What Sling? Dr. DeMers Breaks It Down.
  • Let’s Get Down to Business: Why Most Medical Marketing Fails — and What Actually Works.
  • Come Join Us in Vegas: Regenerative Medicine & Ultrasound, Hands-On and In-Person.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

“Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial

Asarn Wongjarupong, Saran Pairuchvej , Panyajarn Laohapornsvan, Vit Kotheeranurak, Khanathip Jitpakdee, Chunrutai Yeekian and Pongsthorn Chanplakorn

Read the full article here.

Summary:

This randomized controlled trial compared the effectiveness of platelet-rich plasma (PRP) versus traditional epidural steroid injections (ESI) in patients with single-level lumbar disc herniation (HNP) who had failed conservative treatment. Thirty patients were enrolled and randomized into two groups (15 per arm). The PRP group received transforaminal epidural injections prepared from autologous blood, while the ESI group received triamcinolone with lidocaine. Over 24 weeks, patients were assessed for leg pain (LegVAS), back pain (BackVAS), functional disability (ODI), adverse events, and treatment failure. No serious complications occurred in either group.

The study found that PRP significantly outperformed triamcinolone in reducing leg pain at 6, 12, and 24 weeks, with improvements exceeding the minimal clinically important difference. While back pain and disability scores improved in both groups, the PRP group showed comparable or better trends. Additionally, no patients in the PRP group required surgery, unlike the steroid group, where 2 patients did. The findings highlight PRP's regenerative and anti-inflammatory properties, suggesting it as a promising, safe, and longer-lasting alternative for managing lumbar radiculopathy caused by disc herniation.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP’s edge on back pain, smarter marketing, and a live demo invite
Highlights Today’s Research Article: PRP outlasts steroids—stronger, safer, longer relief for back pain. Questions from the Field: From blood draw to injection: PRP takes just 20–25 minutes. Let’s Get Down to Business: Marketing isn’t sales—it’s how patients discover you. Come Join Us: See PRP in action—live demo & Q&A with Dr. Ariana DeMers.   If this newsletter was forwarded to you and you...
Stronger Shoulders, Smarter PRP, Better Marketing
Highlights Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery. Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes. Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age. Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-r...
Grade IV OA? PRP Delivers – Plus, What to Do When Patients Don’t Respond
Highlights Today’s Research Article: Grade IV knee arthritis patients move better, hurt less, and skip the scalpel. Questions from the Field: When PRP results fall short, smart testing and re-dosing can turn non-responders into success stories. Let’s Get Down to Business: Connect, refer, and watch your practice grow. Come Join Us: BOB Live turns knowledge into profit   Turn what you...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.